Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cariprazine as Adjunctive Therapy in Major Depressive Disorder
NCT01469377Phase 2Completed
- Sponsor
- Forest Laboratories
- Start
- Dec 2011
- Primary completion
- Dec 2013
- Modality
- Orthosteric Ligands
- Countries
- 6
01
Overview
A Phase 2 trial of cariprazine in major depressive disorder (MDD), sponsored by Forest Laboratories. Started Dec 2011; status: completed.
02
Drugs
cariprazine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01469377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01469377.